| Mean age (years) |
58 (range: 28-78) |
Gender
Male
Female |
12 (80%)
3 (20%) |
RT sequence
Postoperative IMRT
Definitive IMRT |
8 (54%)
7 (46%) |
Histology
SCC
adenocarcinoma |
13 (87%)
2 (13%) |
Location
nasal cavity
vestibule
ala of the nose |
5 (33.3%)
5 (33.3%)
5 (33.3%) |
RT doses
(5 fractions/week)
35x2=70 Gy
34x2=68Gy
33x2=66 Gy
32x2=64 Gy
31x2=62Gy |
6 (40%)
2 (13%)
5 (33%)
1 (7%)
1 (7%) |
N-status
T1
T2
T3
T4
N1
N2
N3
N4 |
2 (13%)
10 (66%)
1 (7%)
2 (13%)
1
0
0
0 |
| Cisplatin or cetuximab concomitant |
8 (54%) |
